- A natural compound found in small marine snail could be a potent pain reliever
- The compound called Rg1A functions as a pain pathway receptor and helps relieve pain
- Rg1A could be an alternative to opioids, the highly addictive class of painkillers
A compound found
in the marine cone snail may offer an alternative to opioids for pain relief,
finds a study by scientists at the University of Utah. The compound was found
to block pain by targeting a pathway not associated with opioids. The study
conducted in rodents indicate that the benefits continue long after the
compound has cleared the body.
Opioid AbuseOpioids are drugs that are commonly prescribed to relieve pain. Long-term use of opioid can lead to addiction. Opioid abuse is a serious public health issue, which has reached epidemic proportions. According to the Centers for Disease Control and Prevention (CDC), 91 Americans die every day from an opioid overdose. Scientists are looking for alternative therapies that do not rely on the opioid pathways to relieve pain.
"Nature has evolved molecules that are extremely sophisticated and can have unexpected applications," said Baldomera Olivera, Ph.D., professor of biology at the University of Utah. "We were interested in using venoms to understand different pathways in the nervous system."
Marine Cone Snail to Relieve PainIn the current study, the scientists used a small marine snail for the research. The marine cone snail called as Conus regius, commonly found in the Caribbean Sea, packs a venomous punch, which is capable of paralyzing and killing its prey.
The pathway adds to a small number of non-opioid-based pathways, which could be used to develop a treatment for chronic pain. The scientists found that the duration of the pain relief was long, outlasting the presence of the compound in the mouse model.
How Does the Compound Help Relieve PainThe compound was found to have its effect in the body within 4 hours. But, it offers beneficial effect even longer, said the scientists. The snail compound has a restorative effect on the nervous system.
"We found that the compound was still working 72 hours after the injection, still preventing pain," said J. Michael McIntosh, M.D., professor of psychiatry at the University of Utah Health Sciences.
"What is particularly exciting about these results is the aspect of prevention," said McIntosh. "Once chronic pain has developed, it is difficult to treat. This compound offers a potential new pathway to prevent pain from developing in the first place and offer a new therapy to patients who have run out of options."
The scientists hope to continue pre-clinical tests to investigate the safety and effectiveness of a new drug therapy.
Testing the RgIA CompoundPrevious studies have shown that RgIA was effective in the mouse model. The research team wanted to test whether the compound has a positive effect in people. So the team used synthetic chemistry to engineer 20 analogs of the compound.
The scientists started with a key RgIA that fits into a lock, which is the pain pathway receptor -nAChR. RgIA was used as a template to develop new keys called analogs with slightly different configurations.
With the newly developed analogs, the scientists found that RgIA4 tightly bound to the human receptor.
The research team administered the compound to rodents to test its effect. Initially, the rodents were exposed to a Chemotherapy drug, which causes extreme cold sensitivity and hypersensitivity to touch.
"Interactions that are not normally painful, like sheets rubbing against the body or pants against the leg, becomes painful," said McIntosh.
Rodents that were treated with the compound did not experience pain compared to rodents that were not treated with the compound. The findings suggest that nAChR acts as a pain receptor pathway and RgIA4 prevents the receptor from being activated.
Most of the Painkillers that are available today work through a limited number of pathways and are not sufficient to treat pain.
"RgIA4 works by an entirely new pathway, which opens the door for new opportunities to treat pain," said McIntosh. "We feel that drugs that work by this pathway may reduce the burden of opioid use."
The findings are published in the Proceedings of the National Academy of Sciences.
- Compound from Marine Snail Is Potent Pain Reliever - (https://unews.utah.edu/an-alternative-to-opioids-compound-from-marine-snail-is-potent-pain-reliever/)
Please use one of the following formats to cite this article in your essay, paper or report:
Shirley Johanna. (2017, February 21). Snail Venom Could Treat Chronic Pain. Medindia. Retrieved on Aug 19, 2022 from https://www.medindia.net/news/healthinfocus/snail-venom-could-treat-chronic-pain-168005-1.htm.
Shirley Johanna. "Snail Venom Could Treat Chronic Pain". Medindia. Aug 19, 2022. <https://www.medindia.net/news/healthinfocus/snail-venom-could-treat-chronic-pain-168005-1.htm>.
Shirley Johanna. "Snail Venom Could Treat Chronic Pain". Medindia. https://www.medindia.net/news/healthinfocus/snail-venom-could-treat-chronic-pain-168005-1.htm. (accessed Aug 19, 2022).
Shirley Johanna. 2021. Snail Venom Could Treat Chronic Pain. Medindia, viewed Aug 19, 2022, https://www.medindia.net/news/healthinfocus/snail-venom-could-treat-chronic-pain-168005-1.htm.